Successful osimertinib treatment for leptomeningeal carcinomatosis from lung adenocarcinoma with the T790M mutation of EGFR

Lignende værker

• Treatment of EGFR mutation–positive non–small cell lung cancer complicated by Trousseau syndrome with gefitinib followed by osimertinib: a case report
  af: Nonagase, Yoshikane, et al.
  Udgivet: (2018)
• Osimertinib administration via nasogastric tube in an EGFR‐T790M‐positive patient with leptomeningeal metastases
  af: Takeda, Takayuki, et al.
  Udgivet: (2017)
• First- and Second-Generation EGFR-TKIs Are All Replaced to Osimertinib in Chemo-Naive EGFR Mutation-Positive Non-Small Cell Lung Cancer?
  af: Takeda, Masayuki, et al.
  Udgivet: (2019)
• Predicting osimertinib‐treatment outcomes through EGFR mutant‐fraction monitoring in the circulating tumor DNA of EGFR T790M‐positive patients with non‐small cell lung cancer (WJOG8815L)
  af: Sakai, Kazuko, et al.
  Udgivet: (2020)
• Case report: primary resistance to osimertinib in erlotinib-pretreated lung adenocarcinoma with EGFR T790 M mutation
  af: Zheng, Lin-Peng, et al.
  Udgivet: (2018)